Genovac’s core technology, genetic immunization, enables the development of antibodies against any protein target directly from DNA, an electronic sequence, or an accession number.
Find out more
Single B Cell Platforms
Genovac is the premier research partner offering two complimentary automated single B cell antibody discovery platforms for rare antibody discovery; Berkeley Lights’ Beacon single B cell screening and selection platform and the Genovac Nano platform.Find out more
Highly efficient semi-solid and well-based fusion options provide rapid delivery of antibodies that are comparable to yields of manual single B cell platforms.Find out more
Genovac offers in-house hybridoma and single B cell antibody sequencing.Find out more
Transgenic Animal Partners
Genovac is an approved contract research provider with all leading transgenic animal companies.Find out more